Establishment of a human lung cancer cell line with high metastatic potential to multiple organs: Gene expression associated with metastatic potential in human lung cancer

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1727-1735

  Nakano, Tetsuhiro ^a   Shimizu, Kimihiro ^a   Kawashima, Osamu ^a   Kamiyoshihara, Mitsuhiro ^a   Kakegawa, Seiichi ^a   Sugano, Masayuki ^a   Ibe, Takashi ^a   Nagashima, Toshiteru ^a   Kaira, Kyoichi ^a   Sunaga, Noriaki ^a   Ohtaki, Youichi ^a   Atsumi, Jun ^a   Takeyoshi, Izumi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lung cancer; Metastasis; Microarray; Mouse model; Multiple organ

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RAB7 PROTEIN;

ADRENAL METASTASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CARCINOGENICITY; CELL COMMUNICATION; CELL GROWTH; DNA MICROARRAY; DOWN REGULATION; EDG1 GENE; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; HRB2 GENE; HS3ST3A1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAB7 GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION;

ADENOCARCINOMA; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NUCLEAR PORE COMPLEX PROTEINS; RAB GTP-BINDING PROTEINS; RECEPTORS, LYSOSPHINGOLIPID; RNA-BINDING PROTEINS;

EID: 84866440763     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1972     Document Type: Article

References (39)

1. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002. (Pubitemid 41039175)
2. Sawabata N, Asamura H, Goya T, et al: Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol 5: 1369-1375, 2010.
3. Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science 331: 1559-1564, 2011.
4. Fidler IJ and Poste G: The 'seed and soil' hypothesis revisited. Lancet Oncol 9: 808, 2008.
5. Wirtz D, Konstantopoulos K and Searson PC: The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11: 512-522, 2011.
6. Yano S, Nishioka Y, Izumi K, et al: Novel metastasis model of human lung cancer in SCID mice depleted of NK cells. Int J Cancer 67: 211-217, 1996. (Pubitemid 26274152)
7. Kimura K, Nakano T, Park YB, et al: Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma. Clin Exp Metastasis 19: 477-485, 2002. (Pubitemid 35178665)
8. Francia G, Cruz-Munoz W, Man S, Xu P and Kerbel RS: Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 11: 135-141, 2011.
9. Khanna C and Hunter K: Modeling metastasis in vivo. Carcinogenesis 26: 513-523, 2005. (Pubitemid 41214139)
10. Nagamachi Y, Tani M, Shimizu K, Tsuda H, Niitsu Y and Yokota J: Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice. Cancer Lett 127: 203-209, 1998. (Pubitemid 28230805)
11. Jia D, Yan M, Wang X, et al: Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion. BMC Cancer 10: 364, 2010.
12. Nakano T, Tani M, Ishibashi Y, et al: Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis 20: 665-674, 2003. (Pubitemid 37463904)
13. Yokota J: Tumor progression and metastasis. Carcinogenesis 21: 497-503, 2000.
14. Bittner M, Meltzer P, Chen Y, et al: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540, 2000. (Pubitemid 30625740)
15. Hashimoto Y, Shindo-Okada N, Tani M, Takeuchi K, Toma H and Yokota J: Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res 56: 5266-5271, 1996. (Pubitemid 26383046)
16. Clark EA, Golub TR, Lander ES and Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532-535, 2000. (Pubitemid 30625739)
17. Hashimoto Y, Shindo-Okada N, Tani M, et al: Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med 187: 289-296, 1998. (Pubitemid 28080058)
18. Raynaud CM, Mercier O, Dartevelle P, et al: Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer. Clin Lung Cancer 11: 187-191, 2010.
19. Bjorge JD, Pang AS, Funnell M, et al: Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. PLoS One 6: e19309, 2011.
20. Bulk E, Sargin B, Krug U, et al: S100A2 induces metastasis in non-small cell lung cancer. Clin Cancer Res 15: 22-29, 2009.
21. Hoffman RM: Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359, 1999.
22. Sawabata N, Miyaoka E, Asamura H, et al: Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 6: 1229-1235, 2011.
23. Yano S, Shinohara H, Herbst RS, et al: Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res 60: 4959-4967, 2000.
24. Arifin M, Tanimoto K, Putra AC, Hiyama E, Nishiyama M and Hiyama K: Carcinogenesis and cellular immortalization without persistent inactivation of p16/Rb pathway in lung cancer. Int J Oncol 36: 1217-1227, 2010.
25. Noro R, Gemma A, Kosaihira S, et al: Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation. BMC Cancer 6: 277, 2006.
26. Lynch TJ, Bell DW, Sordella R, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139, 2004. (Pubitemid 38637993)
27. Yeh HH, Ogawa K, Balatoni J, et al: Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing non-small cell lung carcinomas using PET/CT. Proc Natl Acad Sci USA 108: 1603-1608, 2011.
28. Lee H, Deng J, Kujawski M, et al: STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med 16: 1421-1428, 2010.
29. Spiegel S and Milstien S: The outs and the ins of sphingosine-1-phosphate in immunity. Nat Rev Immunol 11: 403-415, 2011.
30. Visentin B, Vekich JA, Sibbald BJ, et al: Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9: 225-238, 2006. (Pubitemid 43357948)
31. Chae SS, Paik JH, Furneaux H and Hla T: Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 114: 1082-1089, 2004. (Pubitemid 39578697)
32. Metodieva SN, Nikolova DN, Cherneva RV, Dimova II, Petrov DB and Toncheva DI: Expression analysis of angiogenesis-related genes in Bulgarian patients with early-stage non-small cell lung cancer. Tumori 97: 86-94, 2011.
33. Yamaguchi H, Kitayama J, Takuwa N, et al: Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem J 374: 715-722, 2003. (Pubitemid 37163916)
34. Takuwa Y: Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochim Biophys Acta 1582: 112-120, 2002.
35. Shukla D, Liu J, Blaiklock P, et al: A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99: 13-22, 1999. (Pubitemid 29468626)
36. Arvatz G, Shafat I, Levy-Adam F, Ilan N and Vlodavsky I: The heparanase system and tumor metastasis: is heparanase the seed and soil? Cancer Metastasis Rev 30: 253-268, 2011.
37. Zhang M, Chen L, Wang S and Wang T: Rab7: roles in membrane trafficking and disease. Biosci Rep 29: 193-209, 2009.
38. Frasa MA, Maximiano FC, Smolarczyk K, et al: Armus is a Rac1 effector that inactivates Rab7 and regulates E-cadherin degradation. Curr Biol 20: 198-208, 2010.
39. + exchangers. J Cell Sci 123: 1151-1159, 2010.